Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model
Western diet style (fast food), which includes fatty frozen junk food, lard, processed meats, whole-fat dairy foods, cream, mayonnaise, butter, snacks, and fructose, is a primary etiological determinant for developing nonalcoholic steatohepatitis (NASH) worldwide. Here the primary focus is to see th...
Gespeichert in:
Veröffentlicht in: | Biomedicine & pharmacotherapy 2022-06, Vol.150, p.112956-112956, Article 112956 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 112956 |
---|---|
container_issue | |
container_start_page | 112956 |
container_title | Biomedicine & pharmacotherapy |
container_volume | 150 |
creator | Sabir, Usman Irfan, Hafiz Muhammad Alamgeer Ullah, Aman Althobaiti, Yusuf S. Alshehri, Fahad S. Niazi, Zahid Rasul |
description | Western diet style (fast food), which includes fatty frozen junk food, lard, processed meats, whole-fat dairy foods, cream, mayonnaise, butter, snacks, and fructose, is a primary etiological determinant for developing nonalcoholic steatohepatitis (NASH) worldwide. Here the primary focus is to see the impact of naturally identified essential oil on disease mechanisms developed in an animal model using the same ingredients. Currently, symptomatic therapies are recommended for the management of NASH due to non-availability of specific treatments. Therefore, the present study was designed to evaluate the potential anti-NASH effect of nerolidol in a rat model fed with a purpose-built diet. The diet substantially induced insulin resistance, hepatic steatosis, dyslipidemia, and elevation of liver enzymes in the experimental animals. The levels of liver oxidative stress markers, nitrites (NO2–), serum pro-inflammatory cytokine (TNF-α) and hepatic collagen were increased in disease control rats. Nerolidol oral treatment in ascending dose order of 250 and 500 mg/kg substantially reduced the steatosis (macrovesicular and microvesicular), degeneration of hepatocytes, and inflammatory cells infiltration. The amounts of circulatory TNF-α and tissue collagen were also reduced at 500 mg/kg dose of nerolidol, expressing its anti-fibrotic effect. The current study described the multiple-hit pathophysiology of NASH as enhanced steatosis, pro-inflammatory markers, and oxidative stress in rats, which resulted in the development of vicious insulin resistance. Nerolidol treatment significantly reduced hepatic lipid accumulation and halted disease progression induced by a hypercaloric diet.
[Display omitted]
•Western-diet induced multiple-hit pathogenesis of NASH in the animal model.•Steatosis, inflammation, and oxidative stress crucially contribute to hepatic insulin resistance.•TNF-α and insulin levels are measured through ELISA technique.•Nerolidol prevented the accumulation of fat, AOPP, and collagen in hepatic tissues. |
doi_str_mv | 10.1016/j.biopha.2022.112956 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2654293358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332222003456</els_id><sourcerecordid>2654293358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-18c14ae7b0a77c53e6da751b0917b7b291f3f0c93226e1b8e29184621d82ad9a3</originalsourceid><addsrcrecordid>eNp9UcluFDEUtBCIDIE_QMhHDvTgpd3LBSkKS5AiOABny8vrjEduu7HdRPkifhOPeuDIyZZfvapyFUIvKdlTQru3x712cTmoPSOM7Sllo-geoR0dBWk6QvrHaEd6wRvOGbtAz3I-EkJEx4en6IKLtu1FO-zQ7_fxPiS4W70qLgYcJ3yApd4NnlTByph1Ps_eYBcmr-Z5Q6pg8eR0itllrB9wgBS9s9FXGF7WtMQMWK_OF3wPuUAKjXVQGhfsasDiSlvc4qE5uIKr4iHeQYATWfXw5erbTVVws_J4jhb8c_RkUj7Di_N5iX58_PD9-qa5_frp8_XVbWNaMpSGDoa2CnpNVN8bwaGzqhdUk5H2utdspBOfiBlrJh1QPUB9GdqOUTswZUfFL9HrjXdJ8edafcvZZQPeqwBxzZJ1omUj52Ko0HaDmppBTjDJJVXD6UFSIk8VyaPcKpKniuRWUV17dVZY9Qz239LfTirg3QaA-s9fDpLMxkGombkEpkgb3f8V_gBP6qeq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2654293358</pqid></control><display><type>article</type><title>Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Sabir, Usman ; Irfan, Hafiz Muhammad ; Alamgeer ; Ullah, Aman ; Althobaiti, Yusuf S. ; Alshehri, Fahad S. ; Niazi, Zahid Rasul</creator><creatorcontrib>Sabir, Usman ; Irfan, Hafiz Muhammad ; Alamgeer ; Ullah, Aman ; Althobaiti, Yusuf S. ; Alshehri, Fahad S. ; Niazi, Zahid Rasul</creatorcontrib><description>Western diet style (fast food), which includes fatty frozen junk food, lard, processed meats, whole-fat dairy foods, cream, mayonnaise, butter, snacks, and fructose, is a primary etiological determinant for developing nonalcoholic steatohepatitis (NASH) worldwide. Here the primary focus is to see the impact of naturally identified essential oil on disease mechanisms developed in an animal model using the same ingredients. Currently, symptomatic therapies are recommended for the management of NASH due to non-availability of specific treatments. Therefore, the present study was designed to evaluate the potential anti-NASH effect of nerolidol in a rat model fed with a purpose-built diet. The diet substantially induced insulin resistance, hepatic steatosis, dyslipidemia, and elevation of liver enzymes in the experimental animals. The levels of liver oxidative stress markers, nitrites (NO2–), serum pro-inflammatory cytokine (TNF-α) and hepatic collagen were increased in disease control rats. Nerolidol oral treatment in ascending dose order of 250 and 500 mg/kg substantially reduced the steatosis (macrovesicular and microvesicular), degeneration of hepatocytes, and inflammatory cells infiltration. The amounts of circulatory TNF-α and tissue collagen were also reduced at 500 mg/kg dose of nerolidol, expressing its anti-fibrotic effect. The current study described the multiple-hit pathophysiology of NASH as enhanced steatosis, pro-inflammatory markers, and oxidative stress in rats, which resulted in the development of vicious insulin resistance. Nerolidol treatment significantly reduced hepatic lipid accumulation and halted disease progression induced by a hypercaloric diet.
[Display omitted]
•Western-diet induced multiple-hit pathogenesis of NASH in the animal model.•Steatosis, inflammation, and oxidative stress crucially contribute to hepatic insulin resistance.•TNF-α and insulin levels are measured through ELISA technique.•Nerolidol prevented the accumulation of fat, AOPP, and collagen in hepatic tissues.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2022.112956</identifier><identifier>PMID: 35447548</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Diet, High-Fat ; Diet, Western ; Disease Models, Animal ; Down-Regulation ; Inflammation ; Inflammation - pathology ; Insulin Resistance ; Liver - pathology ; Liver Cirrhosis - drug therapy ; Liver Cirrhosis - pathology ; Mice ; Mice, Inbred C57BL ; Nerolidol ; Non-alcoholic Fatty Liver Disease - drug therapy ; Non-alcoholic Fatty Liver Disease - etiology ; Non-alcoholic Fatty Liver Disease - pathology ; Non-alcoholic steatohepatitis ; Rats ; Sesquiterpenes ; Tumor Necrosis Factor-alpha ; Western diet</subject><ispartof>Biomedicine & pharmacotherapy, 2022-06, Vol.150, p.112956-112956, Article 112956</ispartof><rights>2022 The Authors</rights><rights>Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-18c14ae7b0a77c53e6da751b0917b7b291f3f0c93226e1b8e29184621d82ad9a3</citedby><cites>FETCH-LOGICAL-c408t-18c14ae7b0a77c53e6da751b0917b7b291f3f0c93226e1b8e29184621d82ad9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0753332222003456$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35447548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sabir, Usman</creatorcontrib><creatorcontrib>Irfan, Hafiz Muhammad</creatorcontrib><creatorcontrib>Alamgeer</creatorcontrib><creatorcontrib>Ullah, Aman</creatorcontrib><creatorcontrib>Althobaiti, Yusuf S.</creatorcontrib><creatorcontrib>Alshehri, Fahad S.</creatorcontrib><creatorcontrib>Niazi, Zahid Rasul</creatorcontrib><title>Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model</title><title>Biomedicine & pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>Western diet style (fast food), which includes fatty frozen junk food, lard, processed meats, whole-fat dairy foods, cream, mayonnaise, butter, snacks, and fructose, is a primary etiological determinant for developing nonalcoholic steatohepatitis (NASH) worldwide. Here the primary focus is to see the impact of naturally identified essential oil on disease mechanisms developed in an animal model using the same ingredients. Currently, symptomatic therapies are recommended for the management of NASH due to non-availability of specific treatments. Therefore, the present study was designed to evaluate the potential anti-NASH effect of nerolidol in a rat model fed with a purpose-built diet. The diet substantially induced insulin resistance, hepatic steatosis, dyslipidemia, and elevation of liver enzymes in the experimental animals. The levels of liver oxidative stress markers, nitrites (NO2–), serum pro-inflammatory cytokine (TNF-α) and hepatic collagen were increased in disease control rats. Nerolidol oral treatment in ascending dose order of 250 and 500 mg/kg substantially reduced the steatosis (macrovesicular and microvesicular), degeneration of hepatocytes, and inflammatory cells infiltration. The amounts of circulatory TNF-α and tissue collagen were also reduced at 500 mg/kg dose of nerolidol, expressing its anti-fibrotic effect. The current study described the multiple-hit pathophysiology of NASH as enhanced steatosis, pro-inflammatory markers, and oxidative stress in rats, which resulted in the development of vicious insulin resistance. Nerolidol treatment significantly reduced hepatic lipid accumulation and halted disease progression induced by a hypercaloric diet.
[Display omitted]
•Western-diet induced multiple-hit pathogenesis of NASH in the animal model.•Steatosis, inflammation, and oxidative stress crucially contribute to hepatic insulin resistance.•TNF-α and insulin levels are measured through ELISA technique.•Nerolidol prevented the accumulation of fat, AOPP, and collagen in hepatic tissues.</description><subject>Animals</subject><subject>Diet, High-Fat</subject><subject>Diet, Western</subject><subject>Disease Models, Animal</subject><subject>Down-Regulation</subject><subject>Inflammation</subject><subject>Inflammation - pathology</subject><subject>Insulin Resistance</subject><subject>Liver - pathology</subject><subject>Liver Cirrhosis - drug therapy</subject><subject>Liver Cirrhosis - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Nerolidol</subject><subject>Non-alcoholic Fatty Liver Disease - drug therapy</subject><subject>Non-alcoholic Fatty Liver Disease - etiology</subject><subject>Non-alcoholic Fatty Liver Disease - pathology</subject><subject>Non-alcoholic steatohepatitis</subject><subject>Rats</subject><subject>Sesquiterpenes</subject><subject>Tumor Necrosis Factor-alpha</subject><subject>Western diet</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcluFDEUtBCIDIE_QMhHDvTgpd3LBSkKS5AiOABny8vrjEduu7HdRPkifhOPeuDIyZZfvapyFUIvKdlTQru3x712cTmoPSOM7Sllo-geoR0dBWk6QvrHaEd6wRvOGbtAz3I-EkJEx4en6IKLtu1FO-zQ7_fxPiS4W70qLgYcJ3yApd4NnlTByph1Ps_eYBcmr-Z5Q6pg8eR0itllrB9wgBS9s9FXGF7WtMQMWK_OF3wPuUAKjXVQGhfsasDiSlvc4qE5uIKr4iHeQYATWfXw5erbTVVws_J4jhb8c_RkUj7Di_N5iX58_PD9-qa5_frp8_XVbWNaMpSGDoa2CnpNVN8bwaGzqhdUk5H2utdspBOfiBlrJh1QPUB9GdqOUTswZUfFL9HrjXdJ8edafcvZZQPeqwBxzZJ1omUj52Ko0HaDmppBTjDJJVXD6UFSIk8VyaPcKpKniuRWUV17dVZY9Qz239LfTirg3QaA-s9fDpLMxkGombkEpkgb3f8V_gBP6qeq</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Sabir, Usman</creator><creator>Irfan, Hafiz Muhammad</creator><creator>Alamgeer</creator><creator>Ullah, Aman</creator><creator>Althobaiti, Yusuf S.</creator><creator>Alshehri, Fahad S.</creator><creator>Niazi, Zahid Rasul</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202206</creationdate><title>Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model</title><author>Sabir, Usman ; Irfan, Hafiz Muhammad ; Alamgeer ; Ullah, Aman ; Althobaiti, Yusuf S. ; Alshehri, Fahad S. ; Niazi, Zahid Rasul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-18c14ae7b0a77c53e6da751b0917b7b291f3f0c93226e1b8e29184621d82ad9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Diet, High-Fat</topic><topic>Diet, Western</topic><topic>Disease Models, Animal</topic><topic>Down-Regulation</topic><topic>Inflammation</topic><topic>Inflammation - pathology</topic><topic>Insulin Resistance</topic><topic>Liver - pathology</topic><topic>Liver Cirrhosis - drug therapy</topic><topic>Liver Cirrhosis - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Nerolidol</topic><topic>Non-alcoholic Fatty Liver Disease - drug therapy</topic><topic>Non-alcoholic Fatty Liver Disease - etiology</topic><topic>Non-alcoholic Fatty Liver Disease - pathology</topic><topic>Non-alcoholic steatohepatitis</topic><topic>Rats</topic><topic>Sesquiterpenes</topic><topic>Tumor Necrosis Factor-alpha</topic><topic>Western diet</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sabir, Usman</creatorcontrib><creatorcontrib>Irfan, Hafiz Muhammad</creatorcontrib><creatorcontrib>Alamgeer</creatorcontrib><creatorcontrib>Ullah, Aman</creatorcontrib><creatorcontrib>Althobaiti, Yusuf S.</creatorcontrib><creatorcontrib>Alshehri, Fahad S.</creatorcontrib><creatorcontrib>Niazi, Zahid Rasul</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine & pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sabir, Usman</au><au>Irfan, Hafiz Muhammad</au><au>Alamgeer</au><au>Ullah, Aman</au><au>Althobaiti, Yusuf S.</au><au>Alshehri, Fahad S.</au><au>Niazi, Zahid Rasul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model</atitle><jtitle>Biomedicine & pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2022-06</date><risdate>2022</risdate><volume>150</volume><spage>112956</spage><epage>112956</epage><pages>112956-112956</pages><artnum>112956</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>Western diet style (fast food), which includes fatty frozen junk food, lard, processed meats, whole-fat dairy foods, cream, mayonnaise, butter, snacks, and fructose, is a primary etiological determinant for developing nonalcoholic steatohepatitis (NASH) worldwide. Here the primary focus is to see the impact of naturally identified essential oil on disease mechanisms developed in an animal model using the same ingredients. Currently, symptomatic therapies are recommended for the management of NASH due to non-availability of specific treatments. Therefore, the present study was designed to evaluate the potential anti-NASH effect of nerolidol in a rat model fed with a purpose-built diet. The diet substantially induced insulin resistance, hepatic steatosis, dyslipidemia, and elevation of liver enzymes in the experimental animals. The levels of liver oxidative stress markers, nitrites (NO2–), serum pro-inflammatory cytokine (TNF-α) and hepatic collagen were increased in disease control rats. Nerolidol oral treatment in ascending dose order of 250 and 500 mg/kg substantially reduced the steatosis (macrovesicular and microvesicular), degeneration of hepatocytes, and inflammatory cells infiltration. The amounts of circulatory TNF-α and tissue collagen were also reduced at 500 mg/kg dose of nerolidol, expressing its anti-fibrotic effect. The current study described the multiple-hit pathophysiology of NASH as enhanced steatosis, pro-inflammatory markers, and oxidative stress in rats, which resulted in the development of vicious insulin resistance. Nerolidol treatment significantly reduced hepatic lipid accumulation and halted disease progression induced by a hypercaloric diet.
[Display omitted]
•Western-diet induced multiple-hit pathogenesis of NASH in the animal model.•Steatosis, inflammation, and oxidative stress crucially contribute to hepatic insulin resistance.•TNF-α and insulin levels are measured through ELISA technique.•Nerolidol prevented the accumulation of fat, AOPP, and collagen in hepatic tissues.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>35447548</pmid><doi>10.1016/j.biopha.2022.112956</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0753-3322 |
ispartof | Biomedicine & pharmacotherapy, 2022-06, Vol.150, p.112956-112956, Article 112956 |
issn | 0753-3322 1950-6007 |
language | eng |
recordid | cdi_proquest_miscellaneous_2654293358 |
source | MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals |
subjects | Animals Diet, High-Fat Diet, Western Disease Models, Animal Down-Regulation Inflammation Inflammation - pathology Insulin Resistance Liver - pathology Liver Cirrhosis - drug therapy Liver Cirrhosis - pathology Mice Mice, Inbred C57BL Nerolidol Non-alcoholic Fatty Liver Disease - drug therapy Non-alcoholic Fatty Liver Disease - etiology Non-alcoholic Fatty Liver Disease - pathology Non-alcoholic steatohepatitis Rats Sesquiterpenes Tumor Necrosis Factor-alpha Western diet |
title | Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A29%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Downregulation%20of%20hepatic%20fat%20accumulation,%20inflammation%20and%20fibrosis%20by%20nerolidol%20in%20purpose%20built%20western-diet-induced%20multiple-hit%20pathogenesis%20of%20NASH%20animal%20model&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Sabir,%20Usman&rft.date=2022-06&rft.volume=150&rft.spage=112956&rft.epage=112956&rft.pages=112956-112956&rft.artnum=112956&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2022.112956&rft_dat=%3Cproquest_cross%3E2654293358%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2654293358&rft_id=info:pmid/35447548&rft_els_id=S0753332222003456&rfr_iscdi=true |